Market Forecast Report on Ophthalmic Viscosurgical Devices Market 2017-2027

Ophthalmic viscosurgical devices are a viscoelastic solution which is used during cataract surgery. Ophthalmic viscosurgical devices are also referred as viscoelastic agents, and it is an essential tool for anterior segment surgeon. These devices are also useful to create and maintaining the space in the anterior chamber of the eye during the phacoemulsification and implantation of an intraocular lens. Ophthalmic viscosurgical devices are transparent and gel like substance which has viscous and elastic properties. The majority of ophthalmic viscosurgical devices contain sodium hyaluronate or hydroxypropyl methylcellulose. There are different types of ophthalmic viscosurgical devices are available in the market to support the surgical technique and workflow of cataract surgeon. Broadly, there are two type of ophthalmic viscosurgical devices viz. Cohesive OVD and Dispersive OVD. Cohesive OVDs are a long chain, high weight and high viscosity substance which act like "spaghetti". Dispersive OVD are a short chain, low molecular weight, and low viscosity substances which act like "macaroni". There is less chances of retention and risk of an IOP by use of cohesive OVD whereas dispersive OVD increase the risk of elevated IOP. It is very necessary to select appropriate ophthalmic viscosurgical devices for a particular job by understanding their pros and cons.

Rising cataract procedures worldwide is the primary factor driving the growth of ophthalmic viscosurgical devices market. Lack of awareness of people regarding their regular eye checkup and delayed in disease detection will upsurge the number of cataract surgery globally. Rapid increase in geriatric population results rising incidences of ocular condition such as cataract, high myopia, and diabetic retinopathy. Increasing awareness campaign by NGO’s regarding seriousness about ocular disorder is also expected to be the key factor in the robust growth of ophthalmic viscosurgical devices market. The high risk of elevated IOP during the surgery by use of dispersive OVD will hamper the growth of this market to some extent.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3665

The global ophthalmic viscosurgical devices market is classified on the basis of product type, end user and region.

Based on product type, ophthalmic viscosurgical devices market is segmented into following

• Cohesive OVD

• Dispersive OVD

• Combined

Based on end user, ophthalmic viscosurgical devices market is segmented into following

• Hospital

• Ambulatory Surgical Centers

• Eye Specialty Clinics

The ophthalmic viscosurgical devices market are expected to show exponential growth over the forecast period due to rising number of cataract surgeries globally. According to National Alliance for Eye and Vision Research & National Eye Institute, 0.2 million people across the U.S. are diagnosed age-related macular degeneration, and this number is expected to double by the end of 2020. Favorable reimbursement policies in developed countries will lead to increasing demand of ophthalmic viscosurgical devices. There are various ophthalmic viscosurgical devices are available in the market, and it is broadly classified as cohesive OVD and depressive OVD. Dispersive OVD is expected to gain maximum market share by product type due to its excellent coating and high protection. Based on end user, ophthalmic viscosurgical devices market is segmented as hospitals, ambulatory surgical centers, and specialty eye clinics. Among all end user, hospital segment is expected to dominate the market share owing to more number of cataract surgeries in hospitals.

On the basis of geography, ophthalmic viscosurgical devices market is classified in five key region viz. North America, Latin America, Europe, Asia-Pacific and Middle East and Africa. North America is expected to dominate the ophthalmic viscosurgical devices market by region due to high incidences of cataract surgeries. After North America, ophthalmic viscosurgical devices market is then followed by Europe and Asia-Pacific. Europe ophthalmic viscosurgical devices market is expected to gain significant growth due to favorable reimbursement scenario in this region. In Asia-Pacific region, India and China are the major markets for ophthalmic viscosurgical devices owing to rising geriatric population in these countries.

Examples of some of the market participants in the global ophthalmic viscosurgical devices market identified across the value chain include Carl-Zeiss, Abbott Medical Optics, Alcon, Bausch & Lomb, Hyaltech Ltd., CIMA Technology Inc., and Rayner.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. Fmi is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India